In 2025, the World Health Organisation added semaglutide and other GLP-1 medicines to its Model List of Essential Medicines for selected patients with type 2 diabetes who also have cardiovascular disease, chronic kidney disease or obesity
Safety, Monitoring & Adjustments You should begin with baseline labs, including IGF-1 / GH axis 12 , complete blood count (CBC), metabolic panel (glucose, lipids), liver and kidney function, to detect any underlying issues
The departments comprise quality control, procurement, packaging, testing, warehouse and many more
However, states have greatly varying rules on the other aspects of rendering a treatment that may make it more difficult to use unlicensed MAs